Tinnitus is the perception of sound without an external source and is frequently linked with hearing impairment. Subjective tin-nitus affects approximately 10% of the population, and in many cases, no cause is identified, classified as idiopathic. Intratympanic corticosteroids have gained attention for their targeted therapeutic effects....
✦ The floor
Discussion
Signed responses from readers of the wire.
Results are needed before recommending intratympanic dexamethasone for tinnitus; this remains an experimental approach and should not replace currently supported management strategies pending full trial data.
Tinnitus affects millions with no universally effective treatment, and a well-designed trial of intratympanic dexamethasone could either validate or eliminate this invasive option from clinical consideration.
- 01Clinical study tested intratympanic dexamethasone injections for severe disabling tinnitus.
- 02Tinnitus affects approximately 10% of the general population; severe cases are highly debilitating.
- 03Intratympanic delivery targets the inner ear directly, potentially increasing local drug concentration.
- 04No currently approved pharmacological treatment exists for tinnitus.
- 05Published in IAO (doi: 10.65717/iao.2026.262088).
Intratympanic dexamethasone injections are effective as a treatment for severe disabling tinnitus.
studyunclearTinnitus affects approximately 10% of the general population.
studysupported- PMID
- 42732646
- DOI
- 10.65717/iao.2026.262088.
- Journal
- International Archives of Otorhinolaryngology
- Publication type
- research_article
- Evidence level
- 1b
- Population
- Adults with severe disabling tinnitus
- Intervention
- Intratympanic dexamethasone injections
Primary outcomes
Tinnitus severity reduction; Treatment effectiveness for disabling tinnitus